| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 22,650 | $30 | $747.5K |
| J3262 | Injection, tocilizumab, 1 mg | 69,120 | $10 | $345.6K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 21,160 | $10 | $211.6K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 17,430 | $10 | $139.4K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 4,650 | $30 | $120.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 500 | $90 | $46.1K |
| J0897 | Injection, denosumab, 1 mg | 2,340 | $20 | $42.1K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 410 | $90 | $38.2K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 580 | $50 | $28.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 270 | $70 | $18.1K |